TY - JOUR AU - Torre, L. A. AU - Bray, F. AU - Siegel, R. L. AU - Ferlay, J. AU - Lortet-Tieulent, J. AU - Jemal, A. PY - 2015 DA - 2015// TI - Global cancer statistics, 2012 JO - CA Cancer J Clin VL - 65 UR - https://doi.org/10.3322/caac.21262 DO - 10.3322/caac.21262 ID - Torre2015 ER - TY - JOUR AU - Berek, J. S. AU - Crum, C. AU - Friedlander, M. PY - 2012 DA - 2012// TI - Cancer of the ovary, fallopian tube, and peritoneum JO - Int J Gynaecol Obstet VL - 119 UR - https://doi.org/10.1016/S0020-7292(12)60025-3 DO - 10.1016/S0020-7292(12)60025-3 ID - Berek2012 ER - TY - JOUR AU - Kurman, R. J. AU - Shih, I. -. M. PY - 2010 DA - 2010// TI - The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory JO - Am J Surg Pathol VL - 34 UR - https://doi.org/10.1097/PAS.0b013e3181cf3d79 DO - 10.1097/PAS.0b013e3181cf3d79 ID - Kurman2010 ER - TY - JOUR AU - Mackay, H. J. AU - Brady, M. F. AU - Oza, A. M. AU - Reuss, A. AU - Pujade-Lauraine, E. AU - Swart, A. M. PY - 2010 DA - 2010// TI - Prognostic relevance of uncommon ovarian histology in women with stage III/IV epithelial ovarian cancer JO - Int J Gynecol Cancer VL - 20 UR - https://doi.org/10.1111/IGC.0b013e3181dd0110 DO - 10.1111/IGC.0b013e3181dd0110 ID - Mackay2010 ER - TY - JOUR AU - Gershenson, D. M. AU - Sun, C. C. AU - Bodurka, D. AU - Coleman, R. L. AU - Lu, K. H. AU - Sood, A. K. PY - 2009 DA - 2009// TI - Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant JO - Gynecol Oncol VL - 114 UR - https://doi.org/10.1016/j.ygyno.2009.03.001 DO - 10.1016/j.ygyno.2009.03.001 ID - Gershenson2009 ER - TY - JOUR AU - Grabowski, J. P. AU - Harter, P. AU - Heitz, F. AU - Pujade-Lauraine, E. AU - Reuss, A. AU - Kristensen, G. PY - 2016 DA - 2016// TI - Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase JO - Gynecol Oncol VL - 140 UR - https://doi.org/10.1016/j.ygyno.2016.01.022 DO - 10.1016/j.ygyno.2016.01.022 ID - Grabowski2016 ER - TY - JOUR AU - Plaxe, S. C. PY - 2008 DA - 2008// TI - Epidemiology of low-grade serous ovarian cancer JO - Am J Obstet Gynecol VL - 198 UR - https://doi.org/10.1016/j.ajog.2008.01.035 DO - 10.1016/j.ajog.2008.01.035 ID - Plaxe2008 ER - TY - JOUR AU - Prat, J. PY - 2015 DA - 2015// TI - Pathology of cancers of the female genital tract JO - Int J Gynaecol Obstet VL - 131 UR - https://doi.org/10.1016/j.ijgo.2015.06.010 DO - 10.1016/j.ijgo.2015.06.010 ID - Prat2015 ER - TY - JOUR AU - Schmeler, K. M. AU - Gershenson, D. M. PY - 2008 DA - 2008// TI - Low-grade serous ovarian cancer: a unique disease JO - Curr Oncol Rep VL - 10 UR - https://doi.org/10.1007/s11912-008-0078-8 DO - 10.1007/s11912-008-0078-8 ID - Schmeler2008 ER - TY - JOUR AU - Gourley, C. AU - Farley, J. AU - Provencher, D. M. AU - Pignata, S. AU - Mileshkin, L. AU - Harter, P. PY - 2014 DA - 2014// TI - Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian and primary peritoneal low-grade serous carcinomas JO - Int J Gynecol Cancer VL - 24 UR - https://doi.org/10.1097/IGC.0000000000000257 DO - 10.1097/IGC.0000000000000257 ID - Gourley2014 ER - TY - JOUR AU - Gershenson, D. M. PY - 2016 DA - 2016// TI - Low-grade serous carcinoma of the ovary or peritoneum JO - Ann Oncol VL - 27 UR - https://doi.org/10.1093/annonc/mdw085 DO - 10.1093/annonc/mdw085 ID - Gershenson2016 ER - TY - JOUR AU - Schmeler, K. M. AU - Sun, C. C. AU - Bodurka, D. C. AU - Deavers, M. T. AU - Malpica, A. AU - Coleman, R. L. PY - 2008 DA - 2008// TI - Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum JO - Gynecol Oncol VL - 108 UR - https://doi.org/10.1016/j.ygyno.2007.11.013 DO - 10.1016/j.ygyno.2007.11.013 ID - Schmeler2008 ER - TY - JOUR AU - Escobar, J. AU - Klimowicz, A. C. AU - Dean, M. AU - Chu, P. AU - Nation, J. G. AU - Nelson, G. S. PY - 2013 DA - 2013// TI - Quantification of ER/PR expression in ovarian low-grade serous carcinoma JO - Gynecol Oncol VL - 128 UR - https://doi.org/10.1016/j.ygyno.2012.10.013 DO - 10.1016/j.ygyno.2012.10.013 ID - Escobar2013 ER - TY - JOUR AU - Wong, K. K. AU - Lu, K. H. AU - Malpica, A. AU - Bodurka, D. C. AU - Shvartsman, H. S. AU - Schmandt, R. E. PY - 2007 DA - 2007// TI - Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis JO - Int J Gynecol Pathol VL - 26 UR - https://doi.org/10.1097/pgp.0b013e31803025cd DO - 10.1097/pgp.0b013e31803025cd ID - Wong2007 ER - TY - JOUR AU - Gershenson, D. M. AU - Sun, C. C. AU - Iyer, R. B. AU - Malpica, A. L. AU - Kavanagh, J. J. AU - Bodurka, D. C. PY - 2012 DA - 2012// TI - Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum JO - Gynecol Oncol VL - 125 UR - https://doi.org/10.1016/j.ygyno.2012.02.037 DO - 10.1016/j.ygyno.2012.02.037 ID - Gershenson2012 ER - TY - BOOK AU - Kurman, R. J. AU - Herrington, C. S. AU - Young, R. H. PY - 2014 DA - 2014// TI - WHO Classification of tumors of female reproductive organs PB - International Agency for Research on Cancer CY - Lyon ID - Kurman2014 ER - TY - JOUR AU - Sieh, W. AU - Koebel, M. AU - Longacre, T. A. AU - Bowtell, D. D. AU - Defazio, A. AU - Goodman, M. T. PY - 2013 DA - 2013// TI - Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study JO - Lancet Oncol VL - 14 UR - https://doi.org/10.1016/S1470-2045(13)70253-5 DO - 10.1016/S1470-2045(13)70253-5 ID - Sieh2013 ER - TY - JOUR AU - Rimm, D. L. AU - Nielsen, T. O. AU - Jewell, S. D. AU - Rohrer, D. C. AU - Broadwater, G. AU - Waldman, F. PY - 2011 DA - 2011// TI - Cancer and Leukemia Group B Pathology Committee guidelines for tissue microarray construction representing multicenter prospective clinical trial tissues JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2010.33.2023 DO - 10.1200/JCO.2010.33.2023 ID - Rimm2011 ER - TY - JOUR AU - Yang, X. -. Y. AU - Xi, M. -. R. AU - Yang, K. -. X. AU - Yu, H. PY - 2009 DA - 2009// TI - Prognostic value of estrogen receptor and progesterone receptor status in Chinese young ovarian carcinoma patients JO - Gynecol Oncol VL - 113 UR - https://doi.org/10.1016/j.ygyno.2008.12.018 DO - 10.1016/j.ygyno.2008.12.018 ID - Yang2009 ER - TY - JOUR AU - Nodin, B. AU - Zendehrokh, N. AU - Brandstedt, J. AU - Nilsson, E. AU - Manjer, J. AU - Brennan, D. J. PY - 2010 DA - 2010// TI - Increased androgen receptor expression in serous carcinoma of the ovary is associated with an improved survival JO - J Ovarian Res VL - 3 UR - https://doi.org/10.1186/1757-2215-3-14 DO - 10.1186/1757-2215-3-14 ID - Nodin2010 ER - TY - JOUR AU - Friedrichs, K. AU - Gluba, S. AU - Eidtmann, H. AU - Jonat, W. PY - 1993 DA - 1993// TI - Overexpression of p53 and prognosis in breast cancer JO - Cancer VL - 72 UR - https://doi.org/3.0.CO;2-8 DO - 3.0.CO;2-8 ID - Friedrichs1993 ER - TY - JOUR AU - Buchholz, S. AU - Seitz, S. AU - Schally, A. V. AU - Engel, J. B. AU - Rick, F. G. AU - Szalontay, L. PY - 2009 DA - 2009// TI - Triple-negative breast cancers express receptors for luteinizing hormone-releasing hormone (LHRH) and respond to LHRH antagonist cetrorelix with growth inhibition JO - Int J Oncol VL - 35 ID - Buchholz2009 ER - TY - JOUR AU - Okoye, E. AU - Euscher, E. D. AU - Malpica, A. PY - 2016 DA - 2016// TI - Ovarian Low-grade Serous Carcinoma: A Clinicopathologic Study of 33 Cases With Primary Surgery Performed at a Single Institution JO - Am J Surg Pathol VL - 40 UR - https://doi.org/10.1097/PAS.0000000000000615 DO - 10.1097/PAS.0000000000000615 ID - Okoye2016 ER - TY - JOUR AU - Seidman, J. D. AU - Vang, R. AU - Ronnett, B. M. AU - Yemelyanova, A. AU - Cosin, J. A. PY - 2015 DA - 2015// TI - Distribution and case-fatality ratios by cell-type for ovarian carcinomas: a 22-year series of 562 patients with uniform current histological classification JO - Gynecol Oncol VL - 136 UR - https://doi.org/10.1016/j.ygyno.2014.12.018 DO - 10.1016/j.ygyno.2014.12.018 ID - Seidman2015 ER - TY - JOUR AU - Della Pepa, C. AU - Tonini, G. AU - Santini, D. AU - Losito, S. AU - Pisano, C. AU - Napoli, M. PY - 2015 DA - 2015// TI - Low Grade Serous Ovarian Carcinoma: from the molecular characterization to the best therapeutic strategy JO - Cancer Treat Rev VL - 41 UR - https://doi.org/10.1016/j.ctrv.2014.12.003 DO - 10.1016/j.ctrv.2014.12.003 ID - Della Pepa2015 ER - TY - JOUR AU - Hannibal, C. G. AU - Vang, R. AU - Junge, J. AU - Kjaerbye-Thygesen, A. AU - Kurman, R. J. AU - Kjaer, S. K. PY - 2012 DA - 2012// TI - A binary histologic grading system for ovarian serous carcinoma is an independent prognostic factor: a population-based study of 4317 women diagnosed in Denmark 1978-2006 JO - Gynecol Oncol VL - 125 UR - https://doi.org/10.1016/j.ygyno.2012.02.028 DO - 10.1016/j.ygyno.2012.02.028 ID - Hannibal2012 ER - TY - JOUR AU - Malpica, A. AU - Deavers, M. T. AU - Lu, K. AU - Bodurka, D. C. AU - Atkinson, E. N. AU - Gershenson, D. M. PY - 2004 DA - 2004// TI - Grading ovarian serous carcinoma using a two-tier system JO - Am J Surg Pathol VL - 28 UR - https://doi.org/10.1097/00000478-200404000-00009 DO - 10.1097/00000478-200404000-00009 ID - Malpica2004 ER - TY - JOUR AU - Gershenson, D. M. AU - Sun, C. C. AU - Lu, K. H. AU - Coleman, R. L. AU - Sood, A. K. AU - Malpica, A. PY - 2006 DA - 2006// TI - Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary JO - Obstet Gynecol VL - 108 UR - https://doi.org/10.1097/01.AOG.0000227787.24587.d1 DO - 10.1097/01.AOG.0000227787.24587.d1 ID - Gershenson2006 ER - TY - JOUR AU - Arias-Pulido, H. AU - Smith, H. O. AU - Joste, N. E. AU - Bocklage, T. AU - Qualls, C. R. AU - Chavez, A. PY - 2009 DA - 2009// TI - Estrogen and progesterone receptor status and outcome in epithelial ovarian cancers and low malignant potential tumors JO - Gynecol Oncol VL - 114 UR - https://doi.org/10.1016/j.ygyno.2009.05.045 DO - 10.1016/j.ygyno.2009.05.045 ID - Arias-Pulido2009 ER - TY - JOUR AU - Garcia-Velasco, A. AU - Mendiola, C. AU - Sanchez-Munoz, A. AU - Ballestin, C. AU - Colorner, R. AU - Cortes-Funes, H. PY - 2008 DA - 2008// TI - Prognostic value of hormonal receptors, p53, ki67 and HER2/neu expression in epithelial ovarian carcinoma JO - Clin Transl Oncol VL - 10 UR - https://doi.org/10.1007/s12094-008-0213-x DO - 10.1007/s12094-008-0213-x ID - Garcia-Velasco2008 ER - TY - JOUR AU - Zhao, D. AU - Zhang, F. AU - Zhang, W. AU - He, J. AU - Zhao, Y. AU - Sun, J. PY - 2013 DA - 2013// TI - Prognostic Role of Hormone Receptors in Ovarian Cancer A Systematic Review and Meta-Analysis JO - Int J Gynecol Cancer VL - 23 UR - https://doi.org/10.1097/IGC.0b013e3182788466 DO - 10.1097/IGC.0b013e3182788466 ID - Zhao2013 ER - TY - STD TI - van Kruchten M, van der Marel P, de Munck L, Hollema H, Arts H, Timmer-Bosscha H, et al. Hormone receptors as a marker of poor survival in epithelial ovarian cancer. Gynecol Oncol. 2015. ID - ref32 ER - TY - JOUR AU - Chien, C. H. AU - Chen, C. H. AU - Lee, C. Y. G. AU - Chang, T. C. AU - Chen, R. J. AU - Chow, S. N. PY - 2004 DA - 2004// TI - Detection of gonadotropin-releasing hormone receptor and its mRNA in primary human epithelial ovarian cancers JO - Int J Gynecol Cancer VL - 14 UR - https://doi.org/10.1111/j.1048-891x.2004.014304.x DO - 10.1111/j.1048-891x.2004.014304.x ID - Chien2004 ER - TY - JOUR AU - Mandai, M. AU - Konishi, I. AU - Kuroda, H. AU - Fukumoto, M. AU - Komatsu, T. AU - Yamamoto, S. PY - 1997 DA - 1997// TI - Messenger ribonucleic acid expression of LH/hCG receptor gene in human ovarian carcinomas JO - Eur J Cancer VL - 33 UR - https://doi.org/10.1016/S0959-8049(97)00166-4 DO - 10.1016/S0959-8049(97)00166-4 ID - Mandai1997 ER - TY - JOUR AU - Feng, Z. AU - Wen, H. AU - Bi, R. AU - Ju, X. AU - Chen, X. AU - Yang, W. PY - 2016 DA - 2016// TI - A clinically applicable molecular classification for high-grade serous ovarian cancer based on hormone receptor expression JO - Sci Rep VL - 6 UR - https://doi.org/10.1038/srep25408 DO - 10.1038/srep25408 ID - Feng2016 ER - TY - JOUR AU - Zhang, X. AU - Chen, J. AU - Kang, Y. AU - Hong, S. AU - Zheng, Y. AU - Sun, H. PY - 2013 DA - 2013// TI - Targeted paclitaxel nanoparticles modified with follicle-stimulating hormone beta 81-95 peptide show effective antitumor activity against ovarian carcinoma JO - Int J Pharm VL - 453 UR - https://doi.org/10.1016/j.ijpharm.2013.06.038 DO - 10.1016/j.ijpharm.2013.06.038 ID - Zhang2013 ER - TY - JOUR AU - Engel, J. B. AU - Schally, A. V. AU - Buchholz, S. AU - Seitz, S. AU - Emons, G. AU - Ortmann, O. PY - 2012 DA - 2012// TI - Targeted chemotherapy of endometrial, ovarian and breast cancers with cytotoxic analogs of luteinizing hormone-releasing hormone (LHRH) JO - Arch Gynecol Obstet VL - 286 UR - https://doi.org/10.1007/s00404-012-2335-1 DO - 10.1007/s00404-012-2335-1 ID - Engel2012 ER -